Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Why government's hub-and-spoke figures are 'laughable'

NPA board member Mike Hewitson says dispensing hub predictions don't stack up

EXCLUSIVE

The National Pharmacy Association (NPA) has branded the government’s financial predictions for hub-and-spoke dispensing as “laughable”.

NPA board member Mike Hewitson said the organisation had assessed the Department of Health’s figures on the benefits of running a dispensing hub against the lowest base costs. But the NPA “couldn’t make the finances stack”, he told C+D.

The government had appeared to “exclude all of the inconvenient truths” about the costs of setting up a hub-and-spoke model in its consultation last month, such as capital expenditure costs, Mr Hewitson said.

Using the model will not necessarily save pharmacists any time, Mr Hewitson added, because the legal advice the NPA has taken on the proposals suggested that accuracy checks would still have to be made on prescriptions from a hub before they could be dispensed at a ‘spoke’ pharmacy.

Mr Hewitson predicted that, under a hub-and-spoke model, pharmacists will still have to dispense a much higher number of prescriptions on site than the government’s best-case calculation of 40%.

“All [hub and spoke] does is allow somebody else to stick the label on the box for you,” he said.

"Difficult" to understand business case

NPA spokesperson Gareth Jones told C+D that pharmacists would not benefit financially from any time saved from using a hub-and-spoke model unless the government commissioned additional services, such as a national minor ailments scheme.

It is “difficult” to understand the government’s business case for backing the model, he added.

Mr Jones said the NPA will be sharing its views on the consultation with its members and encouraging them to send their own responses.

“It’s important that the government gets as many informed views as possible here,” he said.

 

The Twitter reaction

 

 


Do you agree with the NPA?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel